ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 11 of 33
Up
УЖМБС 2021, 6(4): 77–82
https://doi.org/10.26693/jmbs06.04.077
Clinical Medicine

Some Predictors of Depressive Disorders in the Context of Clinical Patomorphosis

Belov O. O.
Abstract

The purpose of the study was to study the clinical and psychopathological phenomenology of the initial stage of depressive disorders in the context of clinical pathomorphosis. Materials and methods. Features of clinical symptoms of the initial stage of depressive disorders in the comparative aspect in the context of clinical pathomorphosis based on the analysis of medical records of 236 patients who were treated for depressive disorders in 1971-1995 (ICD-9 codes 296.1, 296.3) and clinical examination of 245 patients with depressive disorders in 2015-2019 (ICD-10 codes F 31.3, F 31.4, F 32.0, F 32.1, F 32.2, F 33.0, F 33.1, F 33.2) are considered. Results and discussion. It was established that there is a predominance in the clinical picture of modern depressive disorders of low mood (in general in 91.4% of patients, 91.6% of men and 91.3% of women, p>0.05), dyssomnia (93.1%, 92.5% and 93.5%, respectively, p>0.05), anxiety, fear (84.5%, 78.5%, 89.1%, respectively, p<0.01), asthenia (82.4%, 77.6% and 86.2%, respectively, p>0.05), somatic vegetative symptoms (82.9%, 77.6% and 87.0%, respectively, p<0.01), apathy (78.8%, 69.2% and 86.2%, respectively, p<0.01) and ideas of self-humiliation and self-blame (69.8%, 72.9% and 67.4%, respectively, p<0.01), and the relatively low prevalence of obsessive symptoms (55.1%, 54.2% and 55.8%, respectively, p<0.05), emotional lability (51.0%, 54.2% and 48.6%, respectively, p<0.01) and cognitive impairment (45.3%, 43.9% and 46.4%, respectively, p<0.05) with a predominance of emotional lability and ideas of self-humiliation and self-blame in men, and manifestations of anxiety, fear, apathy, cognitive impairment, obsessive and somatic vegetative symptoms in women, which gives grounds to consider that the main predictors of depressive disorder at the initial stage of low mood are dyssomnia, anxiety fear, asthenia and somatic vegetative symptoms. The revealed features suggest the presence of a clinical pathomorphosis of depressive disorders. The clinical pathomorphosis of the initial stage of depressive disorders is in a significant reduction in the clinical picture of low mood, ideas of self-abasement and self-blame, emotional lability and cognitive impairment, and an increase in anxiety, fear, asthenia, apathy, obsessive symptoms and obsessive-compulsive symptoms, with significantly greater gender differentiation of clinical symptoms of depression. Conclusion. The identified patterns are embedded in the general trend towards polymorphism and clinical undifferentiation of modern depressive disorders, significant involvement of patients with sleep disorders, asthenic, apathetic and somatic vegetative symptoms, which requires revision of diagnostic strategies and individualization of diagnosis. The identified patterns can be used for early diagnosis of depressive disorders and prevention of depression

Keywords: depressive disorders, pathomorphosis, clinical symptoms

Full text: PDF (Ukr) 314K

References
  1. Global Burden of Disease Study C Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386: 743-800. https://doi.org/10.1016/S0140-6736(15)60692-4
  2. Park LT, Zarate CAJr. Depression in the Primary Care Setting. Reply. N Engl J Med. 2019; 380(23): 2279-80. https://doi.org/10.1056 / NEJMc1903259
  3. Malhi GS, Mann JJ. Depression. Lancet. 2018; 392: 2299-2312. https://doi.org/10.1016/S0140-6736(18)31948-2
  4. Murray CJ. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392: 1789-1858. https://doi.org/10.1016/S0140-6736(18)32279-7
  5. Hockenberry JM, Joski P, Yarbrough C, Druss BG. Trends in treatment and spending for patients receiving outpatient treatment of depression in the United States, 1998-2015. JAMA Psychiatry. 2019; 76: 810-17. https://www.ncbi.nlm.nih.gov/pubmed/31017627. Https://www.ncbi.nlm.nih.gov/pmc/articles/6487900. https://doi.org/10.1001/jamapsychiatry.2019.0633
  6. Bains N, Abdijadid S. Major Depressive Disorder. In: StatPearls. Treasure Island (FL). P. StatPearls Publishing; 2020 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559078/ (date of the application: 01.07.2021).
  7. Skrypnikov AM, Herasimenko LO, Gryn KV. Vikovyj patomorfoz recurrentnyh depresyvnyh rozladiv [Age pathomorphosis of recurrent depressive disorders]. Svit mediciny i biologii. 2016; 4(58): 64-66. [Ukrainian]. https://doi.org/10.1111/dmcn.13242
  8. Rakhman LV, Markova MV. Clinical and therapeutic levels of pathomorphosis of treatment-resistant depression. Med Psychol. 2014; 1: 36-40.
  9. Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. 2012; 6: 369-88. https://www.ncbi.nlm.nih.gov/pubmed/22654508. Https://www.ncbi.nlm.nih.gov/pmc/articles/3363299. https://doi.org/10.2147/PPA.S29716
  10. Markova M, Rezunenko O, Kozhyna H. Contents and efficiency measures of psychoeducation in rehabilitation system of patients with bipolar affective disorder. Journal of Education, Health and Sport Sciences. 2017; 7: 711-5. https://doi.org/10.15587/2519-4798.2017.108070
  11. Peters AT, Shankman SA, Deckersbach T, West AE. Predictors of first-episode unipolar major depression in individuals with and without sub-threshold depressive symptoms: A prospective, population-based study. Psychiatry Res. 2015; 230(2): 150-6. https://www.ncbi.nlm.nih.gov/pubmed/26343831. Https://www.ncbi.nlm.nih.gov/pmc/articles/4692357. https://doi.org/10.1016/j.psychres.2015.08.030
  12. Onchev G. Changes in Psychopathology and Mental Health Resilience. Front Psychiatry. 2021; 12: 676492. https://www.ncbi.nlm.nih.gov/pubmed/34093285. Https://www.ncbi.nlm.nih.gov/pmc/articles/8173063. https://doi.org/10.3389/fpsyt.2021.676492
  13. Wu AFW, Ooi J, Wong PWC., Catmur C, Lau JYF. Evidence of pathological social withdrawal in non-Asian countries: a global health problem. Lancet Psychiatry. 2019; 6: 195-6. https://doi.org/10.1016/S2215-0366(18)30428-0
  14. Hinshaw SP, Scheffler RM. The ADHD Explosion: Myths, Medication, Money, and Today's Push for Performance. NY: Oxford University Press; 2014.
  15. Røtgaard EM, Jensen K, Vergnes JN, Soulières I, Mottron L. Temporal changes in effect sizes of studies comparing individuals with and without autism: a meta-analysis. JAMA Psychiatry. 2019; 76: 1124-32. https://www.ncbi.nlm.nih.gov/pubmed/31433441. Https://www.ncbi.nlm.nih.gov/pmc/articles/6704749. https://doi.org/10.1001/jamapsychiatry.2019.1956
  16. Mysula YI. Osoblyvosti klinichnoj fenomenologii pervynnogo epizodu bipolarnogo afektivnogo rozladu [Features of clinical phenomenology of primary episode of bipolar affective disorder]. Archive of Psychiatry. 2019; 25(1): 11-14. https://doi.org/10.37822/2410-7484.2019.25.3.142-146
  17. Mysula YI, Venger OP. Osoblyvosti dissomnij pry pervynnomu epizodi bipolarnogo afektivnogo rozladu [Features of dyssomny in primary episode of bipolar affective disorder]. Bulletin of National Pirogov Memorial Medical University. 2019; 23(3): 393-6. https://doi.org/10.31393/reports-vnmedical-2019-23(3)-09
  18. Fried EI, Epskamp S, Nesse RM et al. What are "good" depression symptoms? Comparing the centrality of DSM and non‐DSM symptoms of depression in a network analysis. J Affect Disord. 2016; 189: 314‐320. https://www.ncbi.nlm.nih.gov/pubmed/26458184. https://doi.org/10.1016/j.jad.2015.09.005
  19. Haroz EE, Ritchey M, Bass JK, Kohrt BA, Augustinavicius J, Michalopoulos L, et al. How is depression experienced around the world? A systematic review of qualitative literature. Soc Sci Med. 2017; 183: 151‐162. https://www.ncbi.nlm.nih.gov/pubmed/28069271. Https://www.ncbi.nlm.nih.gov/pmc/articles/5488686. https://doi.org/10.1016/j.socscimed.2016.12.030
  20. Maj M, Stein DJ, Parker G, immerman M, Fava GA, De Hert M, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020; 19(3): 269-293. https://www.ncbi.nlm.nih.gov/pubmed/32931110. Https://www.ncbi.nlm.nih.gov/pmc/articles/7491646. https://doi.org/10.1002/wps.20771
  21. Drożdżowicz A. Increasing the Role of Phenomenology in Psychiatric Diagnosis-The Clinical Staging Approach. J Med Philos. 2020; 45(6): 683-702. https://www.ncbi.nlm.nih.gov/pubmed/33094808. Https://www.ncbi.nlm.nih.gov/pmc/articles/7703742. https://doi.org/10.1093/jmp/jhaa022